QuantuMDx at Medica

Drop by our stand at Hall 1 D21 to see for yourself how easy running a 20 minute molecular diagnostic test will be with handheld device Q-POC, or learn more

Share

25 November, Newcastle upon Tyne, UK CSO Jonathan O’Halloran was recently featured on Bloomberg Television’s “Horizons: Saving Lives”, he spoke about Q-POC and the positive impact it will have to

Share

15th October, Utrecht, Holland QuantuMDx announced today that co-founder Jonathan O’Halloran has been awarded the European Chief Technology Officer (CTO) of the Year 2015 in the SME category. Presented by

Share

13th August, Newcastle upon Tyne, UK UK based medical technology developer QuantuMDx has signed a long-term lease with Lugano Property Group to move into a 20,000 square foot bespoke head

Share

28 July 2015, Newcastle upon Tyne UK Earlier this month, CEO Elaine Warburton OBE spoke at Berlin’s Tech Open Air. She said of the event – “’Unconference’ perfectly sums up

Share

12 June 2015, New York, USA Jens Erik Gould featured Q-POC™ in his piece on the future of TB testing, which highlights the need for testing available to rural communities. Go

Share

9 June 2015, Newcastle upon Tyne, UK and Berlin, Germany British medical device developer QuantuMDx (QMDx) and German life sciences company SCIENION have partnered to take QMDx’s highly multiplexed nanowire

Share
Collaboration Needed to Tackle Antimicrobial Resistance

“The world is a funny place; we know the problem with antimicrobial resistance and we know we have the tools to address it, across different disciplines, fields & industries, but

Share

As you will have seen over the past few months the QuantuMDx family has been growing quickly. To accommodate all the current and future Quantumites we’re moving to brand new,

Share

During his latest trip to Cape Town, our CSO Jonathan O’Halloran met with Dr Javid Abdelmoneim to discuss Q-POC and its role in the fight against antibiotic resistance.  

Share